Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Cancer genetics joint venture

Aug. 30, 1996

Inflazyme/SuperGen future licensing agreement

Aug. 30, 1996

Conjugates for cancer/infectious disease treatment covered by U.S. patent

Aug. 30, 1996

LGD-1069 to enter pivotal U.S. trials

Aug. 30, 1996

AG-2034 granted approval for U.S. phase I initiation

Aug. 30, 1996

Phase III trial on Onconase combination initiated

Aug. 30, 1996

Novel antitumor compounds claimed by Kyorin/Sagami

Aug. 23, 1996

Lisofylline undergoes phase III in cancer patients

Aug. 23, 1996

Ethyol extended labeling approved

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...